Literature DB >> 8906762

Acute cognitive impairment in elderly ED patients: etiologies and outcomes.

J L Wofford1, L R Loehr, E Schwartz.   

Abstract

Despite the common occurrence of acute cognitive impairment in elderly emergency department (ED) patients, there is much uncertainty regarding the evaluation and management of this syndrome. We performed a retrospective cohort study of all patients 60 years of age and older transported by emergency medical services (EMS) to hospital EDs in Forsyth County, North Carolina, during 1990 specifically for evaluation of acute cognitive impairment. Five percent (227 of 4,688) of EMS transports during this time period were for the purpose of evaluation of acute cognitive impairment. Compared with community-dwelling patients (n = 105), nursing home patients (n = 47) had a higher prevalence of final ED diagnoses indicative of infection (42.5% v 13.3%) and a lower prevalence of diagnoses indicative of cerebrovascular disease (10.6% v 22.9%) as the etiology of cognitive impairment. The rates of hospitalization and mortality were 74.3% and 28.9%, respectively. The projected aging of the US population and the high prevalence of this syndrome among elderly patients make better understanding of this syndrome essential for ED providers.

Entities:  

Mesh:

Year:  1996        PMID: 8906762     DOI: 10.1016/S0735-6757(96)90080-7

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  31 in total

1.  Prevalence and detection of delirium in elderly emergency department patients.

Authors:  M Elie; F Rousseau; M Cole; F Primeau; J McCusker; F Bellavance
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

Review 2.  Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Horm Behav       Date:  2012-02-18       Impact factor: 3.587

Review 3.  Can consuming flavonoids restore old microglia to their youthful state?

Authors:  Saebyeol Jang; Rodney W Johnson
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 4.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

5.  Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes.

Authors:  Giuseppe P Cortese; Ruth M Barrientos; Steven F Maier; Susan L Patterson
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

6.  Memory impairments in healthy aging: Role of aging-induced microglial sensitization.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Aging Dis       Date:  2010-01-01       Impact factor: 6.745

Review 7.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 8.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

9.  Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.

Authors:  Jing Chen; Jessica B Buchanan; Nathan L Sparkman; Jonathan P Godbout; Gregory G Freund; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2007-10-24       Impact factor: 7.217

Review 10.  Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system.

Authors:  Ryan N Dilger; Rodney W Johnson
Journal:  J Leukoc Biol       Date:  2008-10       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.